The Trump administration is escalating its legal efforts to obtain sensitive medical records of minors undergoing pediatric gender treatments. This move has prompted significant legal scrutiny as a grand jury in Texas seeks to compel healthcare providers to comply with subpoenas for these records.
Legal Challenges and Concerns
Previously, attempts to use administrative subpoenas to access this information were blocked by judges across the political spectrum, who criticized the efforts as unfounded. In response, Texas prosecutors are now employing grand jury subpoenas, a tactic that is historically more challenging to contest. This development has alarmed advocates and families of minors receiving such treatments, which, while not federally illegal, face restrictions in several Republican-led states.
Parents of affected children have expressed concerns about potential retaliation from the administration. One parent, identified as Riley Roe, stated in court documents their fear of their child’s identity being exposed to an administration perceived as hostile to the transgender community.
Federal Investigations and Hospital Responses
The Justice Department’s investigation, which began with over 20 administrative subpoenas last summer, claims to focus on healthcare fraud and false statements related to pediatric gender treatments. At least two hospitals, NYU Langone Hospitals and Stanford University’s Lucile Salter Packard Children’s Hospital, have publicly acknowledged receiving grand jury subpoenas. These subpoenas demand extensive records, including patient identities and parental authorizations.
NYU Langone ceased providing gender-affirming care for minors earlier this year after federal funding threats from the Trump administration. Stanford’s hospital is negotiating to comply with the subpoena while attempting to protect patient privacy through anonymized records.
Upcoming Court Hearings
Several court hearings are scheduled to address these subpoenas. A federal judge in California will consider blocking Stanford’s compliance with respect to six patients. In Maryland, a judge will review a potential nationwide ruling against similar subpoenas. In New York, a judge will hear a request to prevent hospitals from complying with such demands.
The Justice Department argues that identifying individual patients is crucial for investigating potential violations, such as off-label drug use and fraudulent billing. However, legal experts suggest the administration’s credibility is undermined by public comments that question the legitimacy of these investigations.
Original reporting: El Paso News (HLL/CB) — read the source article.
